4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000035
President and CEO sold 17,483 shares at $19.43 ($339,695)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Sale : show line 1 in the form | −17,483 | $19.43 | $339,695 | 2,276,181 | I |
| Open-market sales · 17,483 sh · avg $19.43 · $339,695 | ||||||
Loading xslF345X05/wk-form4_1704846791.xml…